← FDA DRUG APPROVALS
FDA ANDA · ANDA217490
AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE
Sponsor: ALKEM LABS LTD
APPLICATION
ANDA217490
TYPE
ANDA
ORIGINAL APPROVAL
2025-01-21
LATEST ACTION
2025-01-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
AZILSARTAN MEDOXOMIL AND CHLORTHALIDONEPrescription
AZILSARTAN KAMEDOXOMIL EQ 40MG MEDOXOMIL, CHLORTHALIDONE 12.5MG · TABLET · ORAL
AZILSARTAN MEDOXOMIL AND CHLORTHALIDONEPrescription
AZILSARTAN KAMEDOXOMIL EQ 40MG MEDOXOMIL, CHLORTHALIDONE 25MG · TABLET · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.